Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Vimizim patente?

See the DrugPatentWatch profile for Vimizim

What patent covers Vimizim (vimizim)?

The active ingredient in Vimizim is elosulfase alfa, a recombinant form of the enzyme needed to treat mucopolysaccharidosis type IV A (Morquio A syndrome). Patent protection for a medicine like this is usually split across different filings: the drug substance, manufacturing process, formulations, and specific therapeutic uses.

With only the query “Vimizim patente” and no country/jurisdiction, I can’t identify the exact patent number, priority date, or current legal status.

How long does a Vimizim patent last (and when does it expire)?

Drug patents generally have a “20 years from the earliest priority date” framework, but the effective time can be extended by country-specific mechanisms such as supplementary protection certificates (SPCs), and marketing exclusivity rules may add further protection even after patent expiry. Exact timelines require:
- the jurisdiction (e.g., US, EU, UK, Brazil, etc.)
- the specific patent(s) at issue (drug substance vs. process vs. formulation)
- whether any extension/SPC/exclusivity applies

If you tell me the country (or where you saw the word “patente”), I can narrow the search to the relevant expiration window.

Are there legal disputes or “patent challenges” connected to Vimizim?

Patent status for specialty biologics often involves litigation over whether a competitor’s product infringes specific claims, or over validity (e.g., obviousness). Whether this is happening for Vimizim depends on the jurisdiction and the specific patent(s) asserted.

What should I check if I’m looking for the “right” Vimizim patent?

For biologics like elosulfase alfa, the “most relevant” patent can differ depending on the question you’re trying to answer (market entry vs. legal infringement). Common things to verify:
- patent family and the earliest priority date
- which claims are in-force in your country
- any SPC or regulatory data exclusivity timeline tied to the approval
- status in public patent registers (granted, expired, lapsed, or under dispute)

If you meant “Vimizim” patents in a specific country, tell me which one

Reply with:
1) the country (or region), and
2) the patent number if you have it (or a link/screenshot where you saw “Vimizim patente”).

Then I can give you the exact patent coverage and the expected expiry/active status for that jurisdiction.



Other Questions About Vimizim :

Vimizim launch price annual cost 2014? Vimizim launch price annual cost 2014? Vimizim launch price annual cost 2014? Vimizim launch price annual cost 2014?